| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CEO &President | Chairman, CEO &President
1 company
Hunkapiller Michael serves as a Director at PACB. Across recent SEC filings that breaks down to 0 buys and 71 sells. Those positions are worth an estimated $28.3M at current prices.
The biggest single holding is PACB (~$28.3M) as Director. The recent filings there lean toward selling, a net 7,042,889 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2020 | PACB Pacific Biosciences Of California, Inc. | Director | Sell | 1,950,000 | $14.79 | $28,836,800.00 | -80.1% | |
| Aug 25, 2020 | PACB Pacific Biosciences Of California, Inc. | CEO &President | Sell | 487,796 | $6.54 | $3,192,094.10 | -34.3% | |
| Aug 21, 2020 | PACB Pacific Biosciences Of California, Inc. | CEO &President | Sell | 446,401 | $6.51 | $2,906,716.85 | -23.9% | |
| Feb 20, 2020 | PACB Pacific Biosciences Of California, Inc. | Chairman, CEO &President | Sell | 166,575 | $4.50 | $749,754.08 | -8.2% | |
| Feb 19, 2020 | PACB Pacific Biosciences Of California, Inc. | Chairman, CEO &President | Sell | 602,276 | $4.49 | $2,705,644.66 | -22.8% | |
| Feb 19, 2019 | PACB Pacific Biosciences Of California, Inc. | Chairman, CEO &President | Sell | 13,335 | $7.19 | $95,825.31 | -0.6% |